Drug Screening Using IMD in Bladder Cancer

Clinical trial NCT06204614 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06204614
Sponsor: Brigham and Women's Hospital
Status: ENROLLING_BY_INVITATION
Phase: Early Phase 1
Study type: INTERVENTIONAL

Muscle Invasive Bladder Urothelial Carcinoma

Start date: 2024-06-14
Primary completion: 2028-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.